Instil Bio Inc Revenue Growth Rates (TIL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Instil Bio Inc   (NASDAQ: TIL)
 

TIL's Revenue Growth by Quarter and Year

Instil Bio Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TIL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 2.24
1st Quarter March 2.24
FY 4.48





TIL Revenue second quarter 2026 Y/Y Growth Comment
Instil Bio Inc reported Revenue growth of 0.09% year on year in the second quarter 2026, to $ 2.24 millions, this is lower than Instil Bio Inc 's recent average Revenue surge of 383995.94%.

Looking into second quarter 2026 results within Biotechnology & Pharmaceuticals industry 44 other companies have achieved higher Revenue growth. While Instil Bio Inc ' s Revenue increase of 0.09% ranks overall at the positon no. 2808 in the second quarter 2026.


TIL Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -19.13 % - -
3rd Quarter September - 50.34 % - -
2nd Quarter June 0.09 % - - -
1st Quarter March 0 % - - -
FY   - 110.33 % - -

Financial Statements
Instil Bio Inc 's second quarter 2026 Revenue $ 2.24 millions TIL's Income Statement
Instil Bio Inc 's second quarter 2025 Revenue $ 2.24 millions Quarterly TIL's Income Statement


TIL Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 0 % 85.91 % -
3rd Quarter September - 0 % - -
2nd Quarter June 0.09 % 0 % - -
1st Quarter March 0 % -19.13 % - -
FY (Year on Year)   - 110.33 % - -


Back to TIL Growth rate Comparisons >> Back to TIL Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #45
Healthcare Sector #400
Overall #2808

Revenue Y/Y Growth Statistics
High Average Low
3840354.55 % 383995.94 % -100 %
 
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #45
Healthcare Sector #400
Overall #2808
Revenue Y/Y Growth Statistics
High Average Low
3840354.55 % 383995.94 % -100 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Instil Bio Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
7008990.91 % 438058.21 % -100 %
(Jun 30 2016)  


TIL's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Instil Bio Inc disclosed growth in Revenue from the first quarter by 0.09% to $ 2.24 millions, from $ 2.24 millions achived in the previous reporting period.

Within Biotechnology & Pharmaceuticals industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Instil Bio Inc 's Revenue growth quarter on quarter, overall rank is 1792.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #32
Healthcare Sector #237
Overall #1792
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #32
Healthcare Sector #237
Overall #1792
Revenue Q/Q Growth Statistics
High Average Low
7008990.91 % 438058.21 % -100 %
(Jun 30 2016)  


TIL's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Instil Bio Inc disclosed growth in Revenue from the first quarter by 0.09% to $ 2.24 millions, from $ 2.24 millions achived in the previous reporting period.

Within Biotechnology & Pharmaceuticals industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Instil Bio Inc 's Revenue growth quarter on quarter, overall rank is 1792.


Instil Bio Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 8.97 $ 8.97 $ 8.97 $ 9.50 $ 8.75
Y / Y Revenue Growth (TTM) 2.48 % - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) 0 % 0 % -5.6 % 8.56 % -
Seq. Revenue Growth (TTM) Overall Ranking